Voriconazole
Voriconazole is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Voriconazole; Generic name: VORICONAZOLE; Drug class: Azole Antifungal [EPC].
| Brand name | Voriconazole |
|---|---|
| Generic name | VORICONAZOLE |
| Drug class | Azole Antifungal [EPC] |
| Manufacturer | Eugia US LLC |
| Used for | 1 INDICATIONS AND USAGE Voriconazole for injection is an azole antifungal indicated for the treatment of adults and pediatric patients 2 years of age and older with: Invasive aspergillosis ( 1.1 ) Candidemia in non-neutropenics and other deep tissue Candida infections ( 1.2 ) Esophageal candidiasis ( 1.3 ) Serious fungal infections caused by Scedosporium apiospermum and Fusarium species including Fusarium solani , in patients intolerant of, or refractory to, other therapy ( 1.4 ) 1.1 Invasive Aspergillosis Voriconazole for injection is indicated in adults and pediatric patients (2 years of age and older) for the treatment of invasive aspergillosis (IA). In clinical trials, the majority of is |
| Dosage | 2 DOSAGE AND ADMINISTRATION • Dosage in Adults ( 2.3 ) Infection Loading Dose Maintenance Dose Intravenous Infusion Intravenous Infusion Oral Invasive Aspergillosis 6 mg/kg every 12 hours for the first 24 hours 4 mg/kg every 12 hours 200 mg every 12 hours Candidemia in nonneutropenics and other deep tissue Candida infections 3 to 4 mg/kg every 12 hours 200 mg every 12 hours Scedosporiosis and Fusariosis 4 mg/kg every 12 hours 200 mg every 12 hours Esophageal Candidiasis Not Evaluated Not Evaluat |
| Active ingredient(s) | VORICONAZOLE |
| Route | INTRAVENOUS |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=171272c7-d76e-4352-81bc-fcb40386d7d0 |